ANNUAL FINANCIAL REPORT 2010 2010 - TiGenix

and biotech industries through different stages of their growth.Before commencing his MBA, he worked three years as aresearch engineer in environmental biotechnology. Mr. Beyen isa manager of Axxis V&C BVBA, as well as member of the boardof BIO.be, and commissioner for the Flemish government onthe board of the Flemish Institute of Biotechnology (VIB).Claudia D’Augusta: Chief Financial Officer (CFO)With a degree in Economics and a Ph.D. in Finance from theUniversity of Bocconi, Italy, Ms. Claudia D’Augusta has morethan ten years of experience in the field of finance. Aftercompleting her doctorate, she joined the Corporate FinanceDepartment of Deloitte & Touche in Milan. She later joinedApex Partners in Madrid where she was responsible for thecreation and implementation of Transacciones M&A. She wassubsequently Director of Finance for Aquanima (SantanderGroup). Ms. D’Augusta was a member of the executivemanagement of Sensia S.L. from April 2005 until April 2008 andof Genetrix S.L. from February 2006 until February 2008.At present, Ms. D´Augusta is no longer a member of theadministrative, management or supervisory bodies or partnerof any other company or partnership.Wilfried Dalemans: Chief Technical Officer (CTO)Mr. Wilfried Dalemans holds a PhD in molecular biology fromthe Universities of Hasselt and Leuven. Before joining TiGenix,Mr. Dalemans held several senior management positions atGlaxoSmithKline Biologicals, Belgium. As Director regulatorystrategy and development, he was responsible for theworldwide registration of GlaxoSmithKline’s flu franchise. Withthis firm, he also served as Director of molecular biology andresearch, responsible for the development of nucleic acid andtuberculosis vaccines, as well as immunology research activities.Prior to joining GlaxoSmithKline, Mr. Dalemans worked atTransgène, France, where he was responsible for the cysticfibrosis research program.5.4.3 Chief executive officerThe CEO is appointed, and can be removed, by the Board ofDirectors.The CEO is charged by the Board of Directors with theday‐to‐day management of the Company and is therefore alsomanaging director of the Company. In this function, the CEOhas the following general responsibilities:• examining, analysing and proposing to the Board ofDirectors strategic business opportunities that cancontribute to the further growth of the group;• executing the decisions of the Board of Directors;• preparing proposals to the nomination and remunerationcommittee concerning the appointment, remuneration andevaluation of the members of the management team;• setting up, chairing and leading the management team;• managing the members of the management team as theydischarge of their individual responsibilities, as determinedby the CEO;• determining the objectives to be achieved by themanagement;• communicating with the outside world;• ensuring the day-to-day management of the Company andaccounting to the Board of Directors for such managementat regular intervals;• maintaining a continuous dialogue and interaction withthe members of the Board of Directors in an atmosphere ofopenness and a climate of trust;• maintaining excellent relationships with importantcustomers, suppliers and the authorities.The CEO has certain specific tasks. These are further describedin the terms of reference of the CEO, as set out in theCompany’s corporate governance charter.5.4.4 Chief business officerThe CBO is appointed, and can be removed, by the Board ofDirectors. He reports to the CEO.As a managing director, the CBO is responsible for key areas ofstrategic development of the Company and in particular for thefollowing activities:• business development: guiding the Company’s externalgrowth through the identification and realization ofpartnering opportunities and alliances;• intellectual property: ensuring protection of the Company’sdevelopments and alignment of the Company’s activitiesand strategy with its intellectual property portfolio andstrategy;93 •